Innogest Capital logo

Innogest Capital

Europe, Lombardia, Italy, Milan

Description

Innogest Capital, officially known as Innogest SGR S.p.A., is a prominent Italian venture capital firm with a strong focus on seed and early-stage investments across Italy and Europe. Headquartered in Turin, the firm has established itself as a key player in the European startup ecosystem by backing innovative companies with high growth potential. Innogest SGR operates through two specialized funds, each targeting distinct sectors to maximize expertise and impact.

The firm's investment strategy is bifurcated into two main areas. The "Innogest Capital" fund is dedicated to digital startups, typically deploying initial cheques ranging from €200,000 to €2 million. This fund targets companies leveraging technology to disrupt various industries, from software and e-commerce to fintech and AI. Concurrently, the "Innogest Investments" fund focuses on the MedTech sector, providing capital to healthcare technology ventures. For MedTech companies, the typical first investment size ranges from €500,000 to €3 million, reflecting the often higher capital requirements for development and regulatory processes in this field.

Innogest SGR is known for its hands-on approach, providing not just capital but also strategic guidance, industry connections, and operational support to its portfolio companies. With a portfolio exceeding 60 investments and a track record of 10 successful exits, the firm demonstrates a commitment to fostering long-term growth and achieving significant returns. Its dual-fund structure allows for specialized expertise and tailored support, making it a valuable partner for founders navigating the complexities of their respective markets.

Investor Profile

Innogest Capital has backed more than 68 startups, with 1 new investments in the last 12 months alone. The firm has led 25 rounds, about 37% of its total and boasts 11 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Seed, Series A rounds (top funding stages).
  • Majority of deals are located in Italy, United States, Spain.
  • Strong thematic focus on Health Care, Biotechnology, Medical Device.
  • Typical check size: $216K – $3.2M.

Stage Focus

  • Series Unknown (28%)
  • Seed (24%)
  • Series A (22%)
  • Series B (18%)
  • Series C (6%)
  • Post Ipo Equity (3%)

Country Focus

  • Italy (75%)
  • United States (9%)
  • Spain (9%)
  • Switzerland (3%)
  • United Kingdom (3%)
  • Israel (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical Device
  • E-commerce
  • Medical
  • Hospital
  • Fashion
  • Mobile
  • Recycling
  • Sustainability
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Innogest Capital frequently co-invest with?

360 Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Bossa Invest
South America, Sao Paulo, Brazil, São Paulo
Co-Investments: 3
Criteria Venture Tech
Europe, Catalonia, Spain, Barcelona
Co-Investments: 3
Ysios Capital
Europe, Pais Vasco, Spain, San Sebastian
Co-Investments: 3
Endeavor Catalyst
North America, New York, United States, New York
Co-Investments: 2
Atlante Ventures
Europe, Lombardia, Italy, Milano
Co-Investments: 3
Indaco Venture Partners
Europe, Lombardia, Italy, Milan
Co-Investments: 2
Invitalia Ventures
Europe, Lazio, Italy, Rome
Co-Investments: 4
F
Europe, Lombardia, Italy, Milan
Co-Investments: 3
FITEC
Europe, Lombardia, Italy, Milan
Co-Investments: 3

Which angels does Innogest Capital often collaborate with?

GL
Europe, Geneve, Switzerland, Geneva
Shared Deals: 1
Shared Deals: 1
MM
Europe, Lombardia, Italy, Milan
Shared Deals: 1
Shared Deals: 1
BC
Europe, Lombardia, Italy, Milan
Shared Deals: 1
SM
Europe, Italy
Shared Deals: 1
AV
Europe, Lombardia, Italy, Brescia
Shared Deals: 1

What are some of recent deals done by Innogest Capital?

Newronika

Milan, Lombardia, Italy

Newronika restores brain and body functions with innovative technologies.

BioinformaticsBiotechnologyHealth CareHospitalMedical Device
Series BFeb 13, 2025
Amount Raised: $14,162,506
BetaGlue Technologies

Milano, Lombardia, Italy

BetaGlue Technologies engages in research and offers anti-cancer products.

BiotechnologyHealth CareMedicalWellness
SeedJul 20, 2022
Amount Raised: $10,180,832
Renovacor

Philadelphia, Pennsylvania, United States

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.

BiotechnologyHealth CareLife Science
Post Ipo EquitySep 3, 2021
Amount Raised: $30,000,000
GreenBone Ortho

Faenza, Emilia-Romagna, Italy

Wood-derived bone implants for patients with bone fractures.

BiometricsBiopharmaBiotechnologyMedical
Series BApr 13, 2021
Amount Raised: $11,956,002
Everli

Milan, Lombardia, Italy

Everli is a marketplace for online grocery shopping where customers can choose groceries from a variety of retailers.

DeliveryDelivery ServiceE-CommerceGrocerySame Day Delivery
Series CMar 29, 2021
Amount Raised: $100,268,914
Medlumics

Madrid, Madrid, Spain

Medlumics is a startup employing biophotonic technologies to develop products that improve human living standards.

BiotechnologyCRMHealth CareHospitalInformation TechnologyMedical DeviceRobotics
Series UnknownFeb 10, 2021
Amount Raised: $21,813,740
Affera, Inc.

Watertown, Massachusetts, United States

Affera is a medical technology company dedicated to developing innovative solutions for the treatment of cardiac arrhythmia.

BiotechnologyHealth Care
Series UnknownJan 1, 2021
Amount Raised: $5,000,000
Everli

Milan, Lombardia, Italy

Everli is a marketplace for online grocery shopping where customers can choose groceries from a variety of retailers.

DeliveryDelivery ServiceE-CommerceGrocerySame Day Delivery
Series UnknownJan 31, 2020
Amount Raised: $12,204,607
Anaconda BioMed

Barcelona, Catalonia, Spain

Anaconda Biomed is a medical device start-up that develops the next generation of catheters to perform efficient mechanical thrombectomies.

Health CareHospitalMedicalMedical Device
Series BDec 4, 2019
Amount Raised: $22,165,012
Newronika

Milan, Lombardia, Italy

Newronika restores brain and body functions with innovative technologies.

BioinformaticsBiotechnologyHealth CareHospitalMedical Device
Series ASep 25, 2019
Amount Raised: $9,199,138